Advancing Health Equity for More Inclusive Clinical Research at Worldwide Clinical Trials

"I feel like one of the things that has been admirable about H1 amongst several is that, you know, y’all have taken that spectrum and understood what data assets can actually lend value and unlock insight."
-Daniel A. Perez, CCRP, Global Head, Health Equity Strategy at Worldwide Clinical Trials

This video engages with the critical issue of health equity, illustrating how technology, especially AI and analytics, is crucial in transforming our approaches to clinical research and ensuring more inclusive recruitment practices. In this discussion, Daniel Perez takes a deep dive into H1’s strategic initiatives, spotlighting the forward-thinking that guides our development of diversity insights and analytics that propel health equity in clinical research.

Click below to listen to the full discussion with Daniel: